Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04568395 · ClinicalTrials.gov registry record · NA
Acute Effects of TCIG vs ECIG in PLWH
A NA study of Inflammation and Smoking, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 2
- Study locations
NCT04568395 is a NA study of Inflammation and Smoking that has completed, run by University of California, Los Angeles. The registered enrollment target is 37 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04568395, a NA study of Inflammation and Smoking, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 2
- Study locations
Study Summary
Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization and inflammation/oxidative stress.
Conditions Studied
Interventions
- OTHER TCIG
- OTHER ECIG
- OTHER sham control
Study Locations (2)
California
- UCLA - Los Angeles
- UCaliforniaLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2023-05-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04568395
The ClinicalTrials.gov registry entry for NCT04568395 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (87% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Inflammation appearing as the primary indexed condition, and to 3 interventions - of which TCIG is the first listed.
NCT04568395 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04568395 about?
NCT04568395 is a clinical study titled "Acute Effects of TCIG vs ECIG in PLWH". Randomized controlled trial of acute use of electronic cigarette or tobacco cigarette on parameters of ventricular repolarization and inflammation/oxidative stress.
What is the current status of trial NCT04568395?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2020-10-01. Estimated completion is 2023-05-08.
What conditions does trial NCT04568395 study?
This clinical trial studies the following conditions: Inflammation, Smoking, Tobacco Smoking, Oxidative Stress, Vaping.
What interventions are being tested in trial NCT04568395?
The interventions under investigation include: TCIG (OTHER), ECIG (OTHER), sham control (OTHER).
Who is sponsoring clinical trial NCT04568395?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04568395 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.